(Q70741847)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Purification and properties of Bacillus coagulans L-asparaginase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Purification and properties of Bacillus coagulansl-asparaginase (English)

0 references

main subject

Bacillus coagulans

object named as

Bacillus coagulans

1 reference

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

31 January 2024

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

31 January 2024

language of work or name

English

0 references

publication date

1 December 1971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 October 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0003986171904346?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Archives of Biochemistry and Biophysics

31 January 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

744-752

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

Leukæmia-inhibiting Properties and L-Asparaginase Activity of Sera from Certain South American Rodents

13 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

The asparagine deamidase of Bacillus coagulans and Bacillus stearothermophilus

31 January 2024

5

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI

31 January 2024

6

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

L-asparaginases from Mycobacterium tuberculosis strains H37Rv and H37Ra

31 January 2024

8

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

A new L-asparaginase with antitumour activity?

31 January 2024

9

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Purification and properties of an l-asparaginase from Fusarium tricinctum

31 January 2024

11

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects

31 January 2024

13

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance

31 January 2024

14

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. II. Lymphoma 6C3HED cells cultured in a medium devoid of L-asparagine lose their susceptibility to the effects of guinea pig serum in vivo

31 January 2024

15

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Antagonism of purified asparaginase from guinea pig serum toward lymphoma

31 January 2024

17

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Partial purification and antilymphoma activity of Serratia marcescensL-asparaginase

31 January 2024

18

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity

31 January 2024

21

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Purification and Properties of Guinea Pig Serum Asparaginase*

31 January 2024

23

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

The relation of diaphorase and cytochrome reductase

31 January 2024

25

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS

31 January 2024

26

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Formyltetrahydrofolate synthetase: mechanism of cation activation

31 January 2024

30

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

The association-dissociation of formyltetrahydrofolate synthetase and its relation to monovalent cation activation of catalytic activity

31 January 2024

31

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Enzymes activated by monovalent cations

31 January 2024

32

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and

31 January 2024

36

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors

31 January 2024

37

1 reference

https://api.crossref.org/works/10.1016/0003-9861(71)90434-6

31 January 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5171719%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference